Skip to main content

Ethical Aspects of Research in Healthy Volunteers

  • Chapter
  • 45 Accesses

Abstract

Let us begin by making a series of statements with which no reasonable person is likely to disagree:

  1. (1)

    Society derives great benefit from our existing stock of medicines, many of which have been generated by research programmes which include experiments done in healthy volunteers.

  2. (2)

    Present and future research programmes will yield new medicines which will be of great value to society.

  3. (3)

    The development of medicines would be slower, more difficult and more expensive without the participation of healthy volunteers, but it could be done nevertheless.

  4. (4)

    Delay in development of medicines is to the disadvantage of patients.

  5. (5)

    The extra costs of development of drugs are borne by patients, consumers and taxpayers, not by the manufacturer.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Association of the British Pharmaceutical Industry (1988). Guidelines for Medical Experiments in Non-patient Human Volunteers. ABPI, London

    Google Scholar 

  • Beauchamp T. L. and Childress, J. F. (1983). Principles of Biomedical Ethics, 2nd edn. Oxford University Press, Oxford, pp. 148–58

    Google Scholar 

  • Cardon, P. V., Dommel, F. W. Jr and Trumble, R. R. (1976). Injuries to research subjects—a survey of investigators. New Engl. J. Med., 295, 650–4

    Article  CAS  PubMed  Google Scholar 

  • Chaput de Saintonge, D. M., Crane, G. J., Rust, N. D., Karadia, S. and Whittam, L. R. (1988). Modelling determinants of expected rewards in healthy volunteers. Pharm. Med., 3, 45–54

    Google Scholar 

  • Darragh, A., Kenny, M., Lambe, R. and Brick, I. (1985). Sudden death of a volunteer. Lancet., 1, 93–4

    Article  CAS  PubMed  Google Scholar 

  • Dodds-Smith, I. C. (1985). The legal implications of studies in healthy volunteers. BIRA Jl., 4, 88–91

    Google Scholar 

  • Gillon, R. (1986). Philosophical medical ethics: Doctors and patients. Br. Med. J., 292, 466–9

    Article  CAS  Google Scholar 

  • Orme, M., Harry, J. Routledge, P. and Hobson, S. (1989). Healthy volunteer studies in Great Britain: the results of a survey into 12 months’ activity in this field. Br. J. Clin. Pharmacol., 27, 125–33

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Reidenberg, M. M. and Lowenthal, D. T. (1968). Adverse nondrug reactions. New Engl. J. Med., 279, 678–9

    Article  CAS  PubMed  Google Scholar 

  • Royle, J. M. and Snell, E. S. (1986). Medical research on normal volunteers. Br. J. Clin. Pharmacol., 21, 548–9

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Vere, D. W. (1986). Ethics. In Glenny, H. and Nelmes, P. (Eds.), Handbook of Clinical Drug Research. Blackwell Scientific Publications, Oxford, pp. 1–32

    Google Scholar 

  • Vere, D. W. (1988). The ethics of adverse drug reactions. Adverse Drug Reaction Bulletin No. 128, 480–3

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1990 The editors and contributors

About this chapter

Cite this chapter

Warrington, S.J. (1990). Ethical Aspects of Research in Healthy Volunteers. In: O’Grady, J., Linet, O.I. (eds) Early Phase Drug Evaluation in Man. Palgrave, London. https://doi.org/10.1007/978-1-349-10705-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-10705-6_12

  • Publisher Name: Palgrave, London

  • Print ISBN: 978-1-349-10707-0

  • Online ISBN: 978-1-349-10705-6

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics